JO
ALLR

John Overdeck’s Allarity Therapeutics ALLR Stock Holding History

John Overdeck’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5K Hold
27,492
– – ﹤0.01% 4961
2026
Q1 		$30K Hold
27,492
– – ﹤0.01% 4497
2025
Q4 		$29.7K Buy
27,492
+13,582
+98% +$17.3K ﹤0.01% 3972
2025
Q3 		$22K Buy
+13,910
New +$17.5K ﹤0.01% 3595

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

John Overdeck's ALLR Position: Q2 2026 in Review

John Overdeck held its Allarity Therapeutics (ALLR) position steady in Q2 2026 at 27,492 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4961.

John Overdeck first reported a position in ALLR in Q3 2025 and has held it in 4 quarters since. 20 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • John Overdeck held 27,492 shares of Allarity Therapeutics worth $35.5K as of Q2 2026.
  • John Overdeck left its Allarity Therapeutics share count unchanged in Q2 2026.
  • Allarity Therapeutics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4961 holding.
  • John Overdeck first reported a position in Allarity Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 20 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.